Westlake Chemical Partners LP WLKP
$21.48
-$0.04-0.19%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.23B | 1.23B | 1.17B | 1.13B | 1.10B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.23B | 1.23B | 1.17B | 1.13B | 1.10B |
| Cost of Revenue | 849.92M | 847.22M | 818.85M | 784.09M | 734.66M |
| Gross Profit | 384.80M | 387.53M | 347.85M | 349.62M | 367.14M |
| SG&A Expenses | 29.18M | 27.99M | 28.27M | 27.78M | 27.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 879.10M | 875.20M | 847.12M | 811.86M | 762.25M |
| Operating Income | 355.62M | 359.54M | 319.58M | 321.84M | 339.55M |
| Income Before Tax | 335.08M | 338.54M | 299.12M | 302.26M | 320.32M |
| Income Tax Expenses | 590.00K | 617.00K | 547.00K | 556.00K | 730.00K |
| Earnings from Continuing Operations | 334.49 | 337.92 | 298.58 | 301.71 | 319.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -276.89M | -280.00M | -249.88M | -252.55M | -266.95M |
| Net Income | 57.60M | 57.92M | 48.70M | 49.16M | 52.64M |
| EBIT | 355.62M | 359.54M | 319.58M | 321.84M | 339.55M |
| EBITDA | 493.37M | 494.75M | 447.56M | 442.75M | 454.70M |
| EPS Basic | 1.63 | 1.64 | 1.38 | 1.40 | 1.50 |
| Normalized Basic EPS | -1.91 | -1.94 | -1.78 | -1.81 | -1.90 |
| EPS Diluted | 1.63 | 1.64 | 1.38 | 1.40 | 1.50 |
| Normalized Diluted EPS | -1.91 | -1.94 | -1.78 | -1.81 | -1.90 |
| Average Basic Shares Outstanding | 141.20M | 141.19M | 141.18M | 140.59M | 140.59M |
| Average Diluted Shares Outstanding | 141.20M | 141.19M | 141.18M | 140.59M | 140.59M |
| Dividend Per Share | 1.89 | 1.89 | 1.89 | 1.89 | 1.89 |
| Payout Ratio | 115.38% | 114.74% | 136.46% | 135.18% | 126.23% |